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Synaptic plasticity: A role for nitric oxide in LTP
Emily P. Huang
Nitric oxide is back in the spotlight with a new series of
studies showing that it plays an important role in long-
term potentiation, the best-studied type of synaptic
plasticity in the central nervous system thought likely to
play an important role in learning and memory.
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Four years after being named ‘molecule of the year’ [1],
nitric oxide (NO) is still fashionable. A biological role for
this highly soluble, membrane-permeant gaseous mole-
cule was first recognized a decade ago when endothelial-
dependent relaxation factor, an intercellular messenger
mediating vascular relaxation, was identified as NO. Since
this debut, NO has been implicated as a messenger mole-
cule in a variety of cellular functions, including synaptic
plasticity in the central nervous system.
Specifically, researchers have suggested that NO plays a
critical role in the expression of long-term potentiation
(LTP). LTP is a form of synaptic plasticity in which synap-
tic transmission is enhanced for hours or days in response
to repetitive stimulation of presynaptic terminals. One con-
sequence of such repetitive stimulation is an influx of Ca2+
through postsynaptic N-methyl-D-aspartate (NMDA)
receptor channels. Although the chain of events leading to
increased synaptic strength is unknown, this postsynaptic
Ca2+ influx is agreed to be a minimal requirement for LTP
induction. LTP is under intense study because it is
believed to be an important mechanism underlying
memory formation in the brain.
A thorny issue in LTP research is the site of its
expression. That is, the increase in synaptic strength
mediated by LTP may be due to an enhancement of
presynaptic transmitter release or postsynaptic transmit-
ter sensitivity, or both. A number of studies favor the idea
that there is at least some change in presynaptic proper-
ties [2], which begs the question of how events induced
postsynaptically — such as an influx of Ca2+ in the post-
synaptic cell — result in presynaptic changes. The
simple answer involves a membrane-permeant retrograde
‘messenger’: released by the postsynaptic cell, this
messenger would diffuse across the synaptic cleft to the
presynaptic terminal and trigger the changes associated
with LTP (see Fig. 1).
Several candidates for the role of LTP retrograde
messenger have been proposed, including NO. Evidence
that NO is involved in LTP has been mixed, however. Bio-
logically, NO is synthesized from L-arginine, with the stoi-
chiometric production of citrulline, by a family of enzymes
called nitric oxide synthases (NOS). Constitutively
expressed forms of the NOS family are regulated by
Ca2+/calmodulin, providing a potential link to LTP induc-
tion events. In early studies, inhibitors of NOS were
applied to hippocampal slices to see whether they inhib-
ited the expression of LTP [3]. NOS inhibitors, such as
N-nitro-L-arginine and NG-methyl-L-arginine, were found
to block LTP when applied extracellularly or intracellu-
larly to the postsynaptic cell. Hemoglobin, a NO scavenger
which is not taken up by cells, also blocked LTP when
applied extracellularly. These results provided evidence
that NO is involved in LTP of hippocampal synapses, and
that it must be released extracellularly for LTP to occur.
Problems have been raised with this neat picture,
however. Of particular concern is the expression pattern
Figure 1
LTP is dependent on Ca2+ influx through postsynaptic NMDA
receptors. According to the hypothesis that NO acts as a retrograde
messenger, the Ca2+ binds to calmodulin and activates NO synthase,
which converts arginine to NO and citrulline. NO then diffuses to the
presynaptic terminal, leading to enhanced transmitter release.
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of NOS in vivo. Studies conflict on whether neuronal
NOS (nNOS), the major NOS subtype expressed in the
brain, is present in hippocampal pyramidal neurons [4].
Mice with a targeted mutation of the nNOS gene are
capable of normal LTP [5], suggesting this NOS subtype
is not necessary for the expression of LTP. Furthermore,
additional studies show that the blockade of LTP by
NOS inhibitors is decidedly dependent on experimental
conditions, such as temperature or the stimulation pattern
used to induce LTP [2].
At this critical juncture, three studies have come to the
rescue of NO [6–8]. All along there has been the suspicion
that a subtype of NOS other than nNOS might be
involved in LTP. For instance, LTP induced in nNOS
mutant mice can be blocked by NOS inhibitors, indicating
another NOS subtype is active in these synapses. Indeed,
endothelial NOS (eNOS) is well-expressed in hippocam-
pal pyramidal neurons [9]. So Son et al. [6] have performed
the obvious next step: test LTP in mice with targeted
mutations of eNOS and in mice with mutations of both
eNOS and nNOS.
Son et al. [6] found that, like nNOS mutant mice, eNOS
mutant mice express LTP normally. Furthermore, the
addition of NOS inhibitors significantly reduces the LTP
expressed in eNOS mutant mice, again suggesting some
NOS functions in LTP in these mutants — yet another
NOS subtype, perhaps? When Son et al. [6] tested mice
with targeted mutations of both eNOS and nNOS, they
found LTP was reduced in magnitude to about 50 % that
of wild-type mice, and that this level was not further
reduced by NOS inhibitors. From these results, Son et al.
[6] concluded that NO is indeed involved in LTP, but
that the nNOS and eNOS subtypes can compensate for
one another. 
These conclusions must be evaluated in the light of
another recent study, in which Kantor et al. [7] exploited
an intriguing difference between eNOS and nNOS to
distinguish their roles in LTP. Uniquely among the
characterized NOS subtypes, eNOS is localized to the cell
membrane by the cotranslational addition of the fatty acid
myristate to its amino-terminal glycine. This process of
myristoylation is critical to the function of eNOS, facilitat-
ing the extracellular release of NO [10]. 
Kantor et al. [7] tested the effect of disrupting the
myristoylation of eNOS, by incubating hippocampal slices
with hydroxymyristic acid (HMA), an inhibitor of the
enzyme that performs myristoylation. After a day of incuba-
tion in HMA, the slices failed to exhibit LTP. To demon-
strate that this effect was specifically due to disrupted
eNOS function, Kantor et al. [7] constructed a chimeric
molecule consisting of the functional domain of eNOS
fused to the transmembrane domain of CD8, creating a
form of eNOS which localizes to the membrane in the
absence of myristoylation. When hippocampal slices were
transfected with an adenovirus containing this chimera,
LTP was not inhibited by incubation with HMA. This
ingeniously designed rescue experiment demonstrates that
the inhibition of LTP by HMA is specifically due to the
disruption of membrane localization of eNOS.
Kantor et al. [7] concluded that membrane-targeted eNOS
is necessary for LTP, and that its function cannot be com-
pensated by nNOS. This contradicts the results of Son et
al. [6], which imply that nNOS and eNOS can be inter-
changed in LTP function. One possible explanation of
this conflict is that mutant animals deprived through
development of one NOS subtype can compensate with
another subtype, but that adult wild-type animals cannot
do so. If this is the case, the results of the above studies
suggest eNOS is probably the NOS subtype normally
involved in LTP. A further difficulty is that Kantor et al.
[7] found a complete block of LTP when eNOS function
was disrupted, whereas the eNOS/nNOS double mutant
mice studied by Son et al. [6] showed reduced, but still
robust LTP. Given this contradiction, and keeping in
mind the reported variable effects of NOS inhibitors on
LTP, it seems reasonable to think there may be NOS-
dependent and independent components of LTP,
expressed under different conditions. 
While these studies provide evidence that NO is involved
in LTP, little work has been done to address whether NO
acts as the LTP retrograde messenger. A recent study [8]
may ameliorate this state of affairs. In synapses between
cultured hippocampal neurons, an LTP-like phenomenon
is observed when a strong tetanic stimulus is applied to
the presynaptic neuron. Arancio et al. [8] took advantage of
this accessible culture system to test the effects of inject-
ing NO agents into the presynaptic or postsynaptic cell.
For instance, they found that NOS inhibitors blocked
potentiation when injected into the postsynaptic, but not
the presynaptic, cell, consistent with the presumed post-
synaptic origin of a retrograde messenger.
Arancio et al. [8] also found that pairing a weak presynaptic
stimulation, which alone does not result in potentiation,
with a burst of NO — released from a ‘caged’ NO
molecule by photoactivation — induced potentiation of
these hippocampal synapses in culture. This potentiation
was seen whether the NO burst was applied in the post-
synaptic or presynaptic cell. But when the NO burst was
applied in the postsynaptic cell, extracellularly applied
NO scavengers blocked the potentiation, suggesting the
NO must leave the postsynaptic cell to function. When
the NO was applied in the presynaptic cell, however,
extracellularly applied NO scavengers did not block the
potentiation, suggesting NO has its ultimate effect in the
presynaptic cell. 
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This observed behavior fits the profile of the hypothetical
LTP retrograde messenger. Caution is required, however,
in extrapolating these observations to the LTP seen in
brain slices and in vivo. First, there is the question of
whether the observed potentiation phenomenon applies
to LTP. Also, previous studies of the effects of exogenous
NO application on slices have produced mixed results; in
at least one study [11], pairing release of NO from a caged
molecule with weak presynaptic stimulation did not
induce LTP in slices. Caveats aside, the case for NO
being involved in LTP is looking a great deal brighter.
Until recently, it was questionable whether NOS even
existed in the very synapses where it was supposed to act.
Now, eNOS has been definitively localized to hippocam-
pal pyramidal neurons, and nNOS is probably also present
in the same cells. The effects of specifically disrupting
nNOS and/or eNOS by molecular and genetic approaches
indicates NOS, particularly eNOS, plays an significant role
in LTP, at least under some conditions.
Further circumstantial evidence that eNOS generates the
retrograde messenger in LTP induction comes from the
enzyme’s Ca2+/calmodulin regulation and membrane local-
ization. Ca2+ influx through postsynaptic NMDA receptors
could stimulate eNOS production and extracellular release
of NO, which could then diffuse to the presynaptic termi-
nal. How NO would then effect an increase in transmitter
release is a matter for speculation. NO has several known
effectors, particularly soluble guanylyl cyclase, which pro-
duces cGMP, and there is some evidence that cGMP and
cGMP-dependent protein kinase are involved in LTP [12].
Other potential NO targets in LTP include ADP-ribosyl-
transferase and cyclo-oxygenase enzymes.
Although some steps have been made towards confirming
that NO is a retrograde messenger in LTP, much remains
to be done. Further studies must determine, for example,
whether NO really does act presynaptically in LTP, and
must elucidate its mode of action. A major problem is the
confusion over the basic events of LTP — whether there
are presynaptic changes at all — which makes studying
the molecules involved a troublesome business. Difficul-
ties may also arise from the possibility, which may be
related to the confusion just described, that there are NO-
dependent and NO-independent forms of LTP. Sorting
through these issues will ensure that researchers of NO
and LTP are occupied for a while to come.
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